太龙药业完成董事会换届 王荣涛当选董事长

Group 1 - The company, Tailong Pharmaceutical (600222), announced the completion of its board of directors' re-election and the appointment of senior management and securities affairs representatives on August 15 [1] - The newly formed tenth board of directors includes Chairman Wang Rongtao, Vice Chairman Li Jingliang, and other members such as Chen Siliang, Chen Jinge, Luo Jianchao, Chen Qi (independent director with accounting expertise), Liu Yumin (independent director), Fang Liang (independent director), and Chen Fengyun (employee representative director) [1]